Gary Gilmour Selected Research

N- (1- methylethyl)- 5- (pyridin- 4- ylethynyl)pyridine- 2- carboxamide

3/2012

Selective remediation of reversal learning deficits in the neurodevelopmental MAM model of schizophrenia by a novel mGlu5 positive allosteric modulator.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gary Gilmour Research Topics

Disease

11	Schizophrenia (Dementia Praecox) 01/2021 - 08/2009
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2015
3	Cognitive Dysfunction 01/2021 - 10/2010
3	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 08/2015
2	Tauopathies 01/2022 - 09/2017
2	Neurobehavioral Manifestations 03/2012 - 09/2011
1	Neuroinflammatory Diseases 01/2022
1	Dementia (Dementias) 01/2022
1	Memory Disorders (Memory Loss) 01/2022
1	Disease Progression 01/2022
1	Brain Diseases (Brain Disorder) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Epilepsy (Aura) 11/2017
1	Autistic Disorder (Autism) 02/2015
1	Mental Disorders (Mental Disorder) 11/2012
1	Stroke (Strokes) 04/2004

Drug/Important Bio-Agent (IBA)

7	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2013 - 08/2009
6	Pharmaceutical PreparationsIBA 01/2019 - 04/2004
5	N-Methylaspartate (NMDA)IBA 01/2013 - 08/2009
4	Ketamine FDA LinkGeneric 04/2016 - 09/2011
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2016
2	Phencyclidine (Angel Dust)IBA 11/2013 - 04/2010
2	Glutamic Acid (Glutamate)FDA Link 01/2013 - 01/2013
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Trazodone (Trittico)FDA LinkGeneric 01/2022
1	InflammasomesIBA 01/2022
1	Hypnotics and Sedatives (Sedatives)IBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2021
1	Muscarinic M4 ReceptorIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	Biological ProductsIBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	Amyloid beta-PeptidesIBA 01/2019
1	tau Proteins (tau Protein)IBA 01/2019
1	TARPIBA 11/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 11/2017
1	AMPA Receptors (AMPA Receptor)IBA 11/2017
1	LY3130481IBA 11/2017
1	Proteins (Proteins, Gene)FDA Link 11/2017
1	eglumetadIBA 01/2017
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2017
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2017
1	pyridineIBA 03/2012
1	N- (1- methylethyl)- 5- (pyridin- 4- ylethynyl)pyridine- 2- carboxamideIBA 03/2012
1	Endothelin-1 (Endothelin 1)IBA 04/2004

Therapy/Procedure

4	Therapeutics 09/2017 - 03/2012
1	Injections 04/2004